Metraipolis › archive › dc_80f4bfa103fa

Metformin as a Disease-Modifying Agent in Autosomal Dominant Polycystic Kidney Disease: A Systematic Review of Preclinical and Clinical Evidence — Europe PMC PMID:41020837

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41020837
DOI: 10.3390/cimb47090715
License (as archived): solo-consultazione
Archived: 2026-11-10T03:56:39.299Z
SHA-256 of the archived text: 1652e3e8eead3f5dc1bbba242f9411936536b3866d06b445337e360b3d9878be
Stable URL of this page: https://metraipolis.com/documento/dc_80f4bfa103fa

How to cite

Metformin as a Disease-Modifying Agent in Autosomal Dominant Polycystic Kidney Disease: A Systematic Review of Preclinical and Clinical Evidence — Europe PMC PMID:41020837 — Europe PMC (en), https://europepmc.org/article/MED/41020837 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_80f4bfa103fa (Metraipolis archive dc_80f4bfa103fa, sha256 1652e3e8eead3f5dc1bbba242f9411936536b3866d06b445337e360b3d9878be)

BibTeX

@misc{dc80f4bfa103fa,
  title = {Metformin as a Disease-Modifying Agent in Autosomal Dominant Polycystic Kidney Disease: A Systematic Review of Preclinical and Clinical Evidence — Europe PMC PMID:41020837},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41020837},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_80f4bfa103fa; sha256 1652e3e8eead3f5dc1bbba242f9411936536b3866d06b445337e360b3d9878be},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41020837. Agents can read the archived copy with the MCP tool read_document.